Benign neoplasm: Scapula and long bones of upper limb

CD2_BENIGN_BONE_SCAPULA_LONG_UPPER

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D16.0&
  • Hospital discharge: ICD-9 2134
  • Hospital discharge: ICD-8 21303
  • Cause of death: ICD-10 D16.0&
  • Cause of death: ICD-9 2134
  • Cause of death: ICD-8 21303

2 out of 7 registries used, show all original rules.

370

4. Check minimum number of events

None

370

5. Include endpoints

None

370

6. Filter based on genotype QC (FinnGen only)

370

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D16
Name in latin
Neoplasma benignum scapulae sive ossium longorum membri superioris

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3001 1340 1651
Only index persons 2788 1256 1532
Unadjusted period prevalence (%)
Whole population 0.04 0.04 0.05
Only index persons 0.05 0.05 0.06
Median age at first event (years)
Whole population 28.48 34.17 23.81
Only index persons 27.91 34.14 22.80

-FinnGen-

Key figures

All Female Male
Number of individuals 370 196 174
Unadjusted period prevalence (%) 0.07 0.07 0.08
Median age at first event (years) 34.43 34.94 33.86

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
335
Matched controls
3351
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D16.0
ICD-10 Finland
Benign neoplasm: Scapula and long bones of upper limb
+∞
275.5
225
*
21303
ICD-8 Finland
Benign neoplasm of bone and cartilage, Ossium longorum extremitatis superioris et scapulae
+∞
87.4
80
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
77.5
52.1
58
9
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
163.7
41.8
43
*
2134A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Scapula and long bones of upper limb
+∞
32.8
31
*
9102
FHL
Trepanation or removal of the local bone process
101.5
26.1
28
*
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
111.6
19.8
21
*
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
13.6
17.5
30
24
D16.1
ICD-10 Finland
Benign neoplasm: Short bones of upper limb
50.1
16.2
19
*
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
5.4
14.0
43
89
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
52.1
12.9
15
*
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
+∞
11.5
11
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
113.4
10.5
11
*
N02AX02
ATC
tramadol; systemic, rectal
2.1
9.0
143
882
NB1AD
NOMESCO Finland
Shoulder CT examination
19.2
9.0
13
7
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.4
8.7
84
412
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
10.4
8.6
16
16
NB6AA
NOMESCO Finland
Humerus X-ray examination
9.3
8.1
16
18
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
6.7
6.7
16
25
GA1CG
NOMESCO Finland
Extensive MRI of chest
+∞
6.3
6
*
NCR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of elbow or forearm
+∞
6.3
6
*
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
3.3
6.2
30
98
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
6.0
151
1058

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
157
1180
1.57
4.31
2.1
2.0
—
—
—
0
0
63
398
1.70
3.40
1.6
1.3
264.0
544.3
titre
—
10
84
10
28
3.64
3.22
1.6
1.3
76.2
50.1
%
—
5
22
12
39
3.15
3.12
1.9
1.3
—
—
—
0
0
150
1180
1.46
3.05
4.8
5.5
1.2
1.2
mmol/l
0.49
134
1077
11
35
3.21
2.95
1.0
1.1
1.4
4.6
u/ml
—
5
16
10
31
3.29
2.79
1.6
1.3
—
—
—
0
0
104
774
1.48
2.77
3.4
3.5
—
—
—
0
0
5
6
8.42
2.75
4.4
2.8
—
—
—
0
0
160
1294
1.42
2.73
5.3
6.2
1.2
1.2
mmol/l
0.62
130
1102
250
2191
1.43
2.67
4.4
3.8
9.4
10.3
mm/h
0.75
228
2026
98
737
1.45
2.45
2.8
3.3
20.2
233.9
mg/l
1.10
61
492
71
502
1.51
2.41
1.3
1.3
10.1
27.7
iu/ml
4.04
20
175
97
731
1.44
2.39
2.4
2.6
1687.5
6372.6
umol/l
1.35
90
641
14
59
2.43
2.32
1.1
1.1
0.4
1.7
u/ml
—
5
26
13
53
2.51
2.30
1.1
1.0
8.2
8.0
u/ml
—
7
31
37
226
1.71
2.28
1.5
2.4
9.5
10.3
g/l
0.69
30
210
102
783
1.42
2.27
3.5
4.2
3.0
10.1
mg/mmol
3.62
61
513
52
349
1.57
2.23
1.4
1.4
—
—
—
0
0
9
30
3.05
2.16
3.3
1.9
84.5
90.7
%
—
9
30
192
1648
1.34
2.10
4.2
4.2
6.5
6.6
mmol/l
0.46
180
1521
5
10
5.05
2.07
1.8
1.5
—
—
—
0
0
33
201
1.70
2.07
3.5
3.9
1.2
1.2
mmol/l
0.47
26
178
113
903
1.36
1.95
2.1
2.2
—
—
—
0
0
100
784
1.38
1.94
4.0
3.9
7.4
7.4
ph
0.04
22
140
73
542
1.43
1.94
1.4
1.7
393.4
10616147.3
pmol/l
0.50
56
471
68
505
1.42
1.80
1.4
1.3
1.1
8.8
u/ml
3.28
29
196
11
47
2.38
1.79
1.1
1.0
1.5
3.0
u/ml
—
5
25
85
659
1.38
1.76
2.0
1.9
2.9
3.0
mg/l
0.10
73
578
12
54
2.26
1.75
5.0
3.1
—
—
—
0
0
6
18
3.37
1.75
1.3
1.3
—
—
—
0
0
324
3057
1.48
1.72
14.6
13.3
4.0
4.0
mmol/l
0.46
305
2971
5
13
3.88
1.72
1.0
1.0
—
—
—
0
0
37
246
1.56
1.68
4.5
3.4
—
—
—
0
0
8
31
2.61
1.67
1.9
2.3
—
—
—
0
0
8
31
2.61
1.67
1.1
1.4
—
—
—
0
0
6
19
3.19
1.66
1.7
1.2
—
—
—
0
0
224
2008
1.29
1.62
4.2
3.9
—
—
—
0
0
91
723
1.34
1.61
4.3
4.8
—
—
—
0
0
50
359
1.45
1.59
1.4
1.2
—
—
—
0
0
11
50
2.24
1.58
2.8
3.6
3.5
4.4
e9/l
0.93
11
50
11
51
2.19
1.52
3.6
4.1
56.5
57.6
%
0.11
11
51
322
3050
1.43
1.52
14.5
13.2
139.8
139.7
mmol/l
0.23
305
2970
7
28
2.53
1.46
1.0
1.4
—
—
—
0
0
11
53
2.11
1.40
1.9
1.2
—
—
—
0
0
11
53
2.11
1.40
1.8
1.5
—
—
—
0
0
5
17
2.97
1.36
1.0
1.1
—
—
—
0
0
14
75
1.90
1.36
1.2
1.5
—
—
—
0
0
24
152
1.62
1.35
5.0
8.4
92.8
94.0
%
0.23
24
152
124
1053
1.27
1.33
8.5
7.0
1.2
1.2
inr
0.40
39
328
8
34
2.38
1.30
1.1
1.4
0.5
0.5
nmol/l
—
8
29
8
35
2.31
1.27
2.9
2.9
—
—
—
0
0
243
2240
1.25
1.22
6.6
7.3
74.7
76.2
u/l
0.28
234
2107
133
1150
1.24
1.20
3.5
4.5
36.5
36.3
g/l
0.16
126
1080
14
79
1.80
1.18
1.1
1.2
—
70.0
—
0
7
163
1443
1.23
1.18
3.8
3.2
0.0
0.0
estimate
0.00
37
278
41
302
1.40
1.17
26.9
21.1
1.2
1.3
inr
—
7
44
91
755
1.27
1.17
3.2
2.7
—
—
—
0
0
11
194
0.55
1.12
1.4
1.6
—
—
—
0
0
167
1490
1.22
1.11
4.5
6.1
10.5
11.3
umol/l
0.61
157
1409
113
968
1.24
1.10
4.7
5.4
—
—
—
0
0
165
1471
1.22
1.10
3.7
3.3
0.0
0.0
estimate
0.00
34
268
167
1492
1.22
1.09
5.5
5.6
0.6
0.6
e9/l
0.52
151
1303
11
59
1.89
1.08
1.0
1.2
—
—
—
0
0
156
1385
1.22
1.08
4.1
3.8
—
—
—
0
0
99
838
1.25
1.07
2.8
3.1
8.3
8.3
mmol/l
0.02
81
718
10
52
1.95
1.07
1.8
3.1
—
—
—
0
0
23
155
1.52
1.04
3.0
4.6
—
—
—
0
0
5
22
2.29
1.03
1.0
1.3
13.9
10.8
umol/l
—
5
22
9
47
1.94
1.03
1.0
1.0
—
—
—
0
0
162
1450
1.21
1.02
4.8
4.4
0.0
0.0
estimate
0.00
36
285
33
242
1.40
0.99
4.6
7.5
94.0
95.9
%
0.52
33
232
44
339
1.34
0.98
3.5
5.9
1.0
1.0
mmol/l
0.52
44
315
166
1494
1.20
0.98
5.6
5.6
0.0
0.0
e9/l
0.90
148
1312
0
32
0.00
0.95
0.0
19.4
—
1608.7
—
0
32
0
32
0.00
0.95
0.0
12.7
—
875.0
—
0
32
120
1052
1.21
0.93
4.1
3.4
37.1
38.1
ng/l
0.03
76
650
106
918
1.22
0.92
2.2
3.3
2.3
2.4
mmol/l
0.27
97
817
89
757
1.23
0.92
5.7
6.9
—
—
—
0
0
6
29
2.09
0.89
1.8
1.4
—
—
—
0
0
6
29
2.09
0.89
1.0
1.2
—
—
—
0
0
6
30
2.02
0.87
1.2
1.4
—
—
—
0
0
41
319
1.32
0.87
1.2
1.3
—
—
—
0
0
35
266
1.35
0.86
4.8
7.0
5.4
5.2
kpa
0.57
35
254
35
266
1.35
0.86
4.8
7.0
12.6
12.4
kpa
0.05
35
255
242
2271
1.19
0.84
4.2
3.9
14.4
14.6
pmol/l
0.68
223
2088
90
779
1.21
0.79
4.5
3.6
0.0
0.0
estimate
0.69
35
277
8
48
1.68
0.79
1.6
1.4
—
—
—
0
0
317
3059
1.25
0.78
13.6
12.2
25.3
21.8
mg/l
0.79
247
2380
32
244
1.34
0.78
2.2
4.3
—
—
—
0
0
29
218
1.36
0.78
4.7
5.9
1.2
1.4
mmol/l
0.54
29
211
169
1547
1.17
0.78
5.5
5.6
1.8
2.0
e9/l
1.22
154
1381
15
99
1.54
0.77
4.3
4.8
—
—
—
0
0
30
230
1.33
0.72
4.8
7.5
127.3
122.2
g/l
0.77
30
219
17
118
1.46
0.70
1.2
1.2
—
—
—
0
0
9
58
1.57
0.70
1.3
1.4
1.0
0.9
nmol/l
—
9
53
7
41
1.72
0.70
2.4
1.3
—
—
—
0
0
81
705
1.19
0.67
4.8
4.1
—
—
—
0
0
5
28
1.80
0.66
1.2
1.1
275.6
249.3
pmol/l
—
5
21
167
1545
1.15
0.64
5.7
5.9
0.2
0.2
e9/l
0.03
150
1377
70
606
1.19
0.62
1.6
1.4
21.9
21.5
nmol/l
0.07
63
522
24
183
1.33
0.61
1.5
1.5
2.6
1.2
g/l
0.41
19
173
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
285
2744
1.17
0.60
5.2
5.1
39.2
39.3
mmol/mol
0.10
264
2587
299
2890
1.18
0.59
4.3
4.1
6.0
5.8
mmol/l
1.07
275
2679
286
2755
1.17
0.59
4.9
4.5
10.4
2.3
mu/l
0.46
262
2560
17
230
0.73
0.59
3.3
3.5
—
—
—
0
0
0
23
0.00
0.58
0.0
2.3
—
63.2
—
0
14
12
81
1.50
0.57
2.3
4.1
3.8
3.9
mmol/l
0.66
12
74
184
1726
1.13
0.55
6.7
9.2
4.2
4.0
e9/l
0.57
162
1528
350
3440
1.32
0.54
19.2
17.8
30.0
30.3
pg
1.53
341
3398
17
226
0.74
0.54
3.4
3.6
5.9
5.8
kpa
0.18
17
219
116
1058
1.14
0.54
2.1
1.8
101.4
94.5
pmol/l
0.58
63
572
350
3441
1.32
0.53
19.3
17.9
4.6
4.6
e12/l
0.33
334
3360
350
3441
1.32
0.53
19.2
17.8
90.2
90.6
fl
0.81
341
3400
92
827
1.15
0.52
3.4
2.8
—
—
—
0
0
15
109
1.39
0.51
2.3
1.8
20.7
21.8
s
0.46
15
98
16
118
1.37
0.51
2.8
2.2
—
—
—
0
0
350
3443
1.31
0.51
19.3
17.9
6.6
6.7
e9/l
0.38
332
3362
331
3238
1.21
0.50
12.5
11.3
—
—
—
0
0
350
3444
1.30
0.50
19.5
18.0
137.5
137.5
g/l
0.00
342
3402
18
137
1.33
0.48
1.0
1.1
—
—
—
0
0
7
47
1.50
0.48
3.0
3.1
—
—
—
0
0
57
498
1.17
0.47
3.4
3.6
2240.0
421.4
ng/l
0.44
40
354
17
129
1.33
0.46
2.7
2.4
8849.9
4346.2
u/l
—
5
54
45
387
1.19
0.45
1.2
1.3
—
—
—
0
0
84
760
1.14
0.44
2.8
2.8
—
—
—
0
0
109
1004
1.12
0.43
3.2
3.6
22.4
100.1
e6/l
1.54
77
719
74
665
1.14
0.43
1.4
1.3
2.2
2.4
g/l
0.79
46
420
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
6
94
0.63
0.42
3.7
5.3
0.7
1.0
%
—
6
85
6
94
0.63
0.42
3.7
5.3
2.2
1.6
%
—
6
84
23
186
1.25
0.41
1.2
1.3
—
39.3
—
0
10
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
0
15
0.00
0.41
0.0
6.1
—
—
—
0
0
16
123
1.31
0.41
6.1
9.0
—
—
—
0
0
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
214
2051
1.10
0.39
4.0
3.4
—
—
—
0
0
0
19
0.00
0.39
0.0
2.0
—
—
—
0
0
21
257
0.81
0.38
1.2
1.4
—
—
—
0
0
8
112
0.71
0.38
2.6
3.6
9.3
2304.9
u/ml
—
8
99
25
208
1.22
0.36
2.3
2.4
—
7.6
—
0
7
144
1359
1.10
0.36
5.5
5.6
0.6
0.7
%
0.26
134
1276
5
79
0.63
0.36
1.4
1.3
—
—
—
0
0
84
772
1.11
0.35
2.8
2.9
0.3
0.3
e6/l
0.03
64
592
149
1410
1.09
0.35
5.8
5.8
8.7
8.5
%
0.41
140
1331
92
851
1.11
0.34
2.8
3.1
26.9
133.6
e6/l
0.80
72
667
148
1402
1.09
0.34
5.5
5.6
3.0
2.8
%
0.41
139
1311
6
46
1.31
0.33
1.7
1.5
—
—
—
0
0
348
3438
1.21
0.32
19.4
17.9
259.6
251.7
e9/l
1.58
333
3362
19
156
1.23
0.31
4.5
7.3
25.4
24.9
mmol/l
0.22
19
144
15
120
1.26
0.30
1.9
1.6
—
—
—
0
0
72
662
1.11
0.30
1.9
1.7
0.7
1.1
mg/l
1.62
56
501
10
75
1.34
0.30
2.3
2.6
11.6
138.5
ug/min
—
5
46
8
108
0.74
0.29
1.6
1.9
1.6
1.4
g/l
—
8
90
26
223
1.18
0.29
4.9
7.7
7.9
9.0
mmol/l
0.43
26
215
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
71
656
1.10
0.28
3.8
3.4
—
—
—
0
0
84
783
1.09
0.27
1.6
1.7
1.5
1.4
mmol/l
0.32
72
675
142
1354
1.08
0.27
10.6
8.7
0.0
0.0
e9/l
0.55
117
1116
20
169
1.19
0.26
1.2
1.2
—
—
—
0
0
52
474
1.11
0.26
1.9
1.6
1205.7
1163.6
nmol/l
0.11
38
366
23
198
1.17
0.25
6.0
7.6
—
—
—
0
0
16
191
0.83
0.25
3.1
2.6
4.9
4.6
kpa
0.22
16
184
10
126
0.79
0.24
1.1
1.5
—
—
—
0
0
16
188
0.84
0.22
2.1
2.5
—
—
—
0
0
5
42
1.19
0.21
2.6
4.9
423.4
361.4
umol/l
—
5
36
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
0.8
—
0
5
63
588
1.09
0.21
2.3
2.6
2.7
4.9
e6/l
1.85
55
520
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
60
559
1.09
0.20
3.1
2.8
0.8
0.7
ug/l
0.15
41
337
10
123
0.81
0.20
2.0
3.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
10
122
0.81
0.19
3.8
2.9
—
—
—
0
0
28
251
1.12
0.19
1.3
1.5
—
—
—
0
0
36
328
1.11
0.19
1.3
1.4
—
—
—
0
0
33
363
0.90
0.19
1.6
1.8
—
—
—
0
0
17
147
1.16
0.18
1.9
3.2
0.0
0.1
e6/l
1.92
17
140
14
119
1.18
0.18
1.0
1.5
341.9
239.8
miu/ml
—
7
61
151
1462
1.06
0.18
5.6
5.6
27.7
28.6
%
0.51
143
1377
5
66
0.75
0.17
4.8
3.7
—
—
—
0
0
85
891
0.94
0.17
1.6
1.5
—
—
—
0
0
5
70
0.71
0.17
1.0
1.3
—
—
—
0
0
11
130
0.84
0.16
1.0
1.3
—
—
—
0
0
6
78
0.77
0.15
1.0
1.2
—
—
—
0
0
149
1447
1.05
0.15
5.4
5.4
57.1
56.7
%
0.16
141
1367
138
1338
1.05
0.15
2.8
2.6
115.2
103.8
ug/l
0.37
124
1258
11
93
1.19
0.14
2.6
1.9
1.7
1.6
ug/l
0.02
11
83
61
643
0.94
0.14
4.3
3.6
1.0
1.0
kg/l
—
9
83
77
736
1.06
0.14
1.3
1.3
1.7
1.4
u/ml
0.15
21
200
8
96
0.83
0.14
1.1
1.2
—
—
—
0
0
305
3018
1.06
0.13
4.4
4.2
4.7
4.7
mmol/l
0.19
281
2841
38
406
0.93
0.13
2.0
2.3
13.5
13.9
umol/l
0.10
33
380
41
386
1.07
0.12
1.4
2.2
77.4
128.8
ug/g
1.25
30
309
12
105
1.15
0.11
1.1
1.8
—
—
—
0
0
70
673
1.05
0.11
1.8
1.9
—
—
—
0
0
25
231
1.09
0.11
1.0
1.3
74.0
150.8
iu/ml
—
6
95
39
368
1.07
0.11
1.6
1.7
—
—
—
0
0
23
212
1.09
0.10
4.2
3.7
—
—
—
0
0
23
212
1.09
0.10
1.4
1.4
—
—
—
0
0
43
409
1.06
0.09
1.1
1.3
—
—
—
0
0
10
87
1.15
0.09
1.0
1.1
—
—
—
0
0
5
63
0.79
0.08
1.0
1.3
—
—
—
0
0
10
88
1.14
0.08
1.3
1.4
—
—
—
0
0
17
156
1.09
0.08
2.2
2.0
—
—
—
0
0
11
98
1.13
0.07
1.8
2.7
—
—
—
0
0
53
549
0.96
0.07
1.4
1.7
—
—
—
0
0
9
88
1.02
0.07
1.2
1.4
—
—
—
0
0
17
158
1.08
0.06
1.1
1.7
—
—
—
0
0
17
159
1.07
0.05
1.1
1.7
—
—
—
0
0
10
110
0.91
0.05
2.6
3.6
24.1
24.0
mmol/l
—
10
103
123
1244
0.98
0.03
2.4
2.6
—
—
—
0
0
305
3062
0.98
0.03
4.6
4.5
2.9
2.8
mmol/l
0.20
281
2864
10
92
1.09
0.03
1.4
1.4
—
—
—
0
0
288
2892
0.98
0.03
12.8
12.4
41.1
40.6
%
0.49
208
2279
11
102
1.08
0.03
1.4
1.6
—
—
—
0
0
34
349
0.97
0.02
1.9
1.5
—
—
—
0
0
89
899
0.99
0.01
2.5
2.4
56.6
55.5
u/l
0.11
83
836
14
146
0.96
0.00
1.1
1.7
—
—
—
0
0
27
264
1.02
0.00
1.4
1.2
—
—
—
0
0
40
406
0.98
0.00
1.5
1.6
—
—
—
0
0
55
544
1.01
0.00
2.7
2.5
585.2
569.3
mosm/kgh2o
0.19
46
467
32
318
1.01
0.00
5.4
6.3
102.7
104.0
mmol/l
0.94
32
310
291
2909
1.00
0.00
3.9
3.7
1.3
1.3
mmol/l
0.32
272
2721
16
163
0.98
0.00
1.1
1.1
—
—
—
0
0
16
157
1.02
0.00
1.1
1.7
—
—
—
0
0
11
105
1.05
0.00
24.4
9.8
—
—
—
0
0
24
245
0.98
0.00
1.5
1.4
—
—
—
0
0
41
405
1.01
0.00
3.1
1.9
—
—
—
0
0
300
3004
0.99
0.00
4.3
4.1
1.4
1.4
mmol/l
1.15
279
2814
19
186
1.02
0.00
1.3
1.2
—
—
—
0
0
40
404
0.99
0.00
1.7
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
79.1
—
0
8
0
8
0.00
0.00
0.0
2.1
—
13.4
—
0
8
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
7
78
0.90
0.00
1.0
1.3
488.4
445.1
mg/l
—
7
71
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
2.0
—
0
6
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
6
69
0.87
0.00
1.0
1.2
3.5
3.7
mmol/l
—
6
61
16
160
1.00
0.00
1.1
1.7
—
—
—
0
0
8
79
1.01
0.00
2.1
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
5.1
—
45.4
—
0
9
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
3.0
—
1.1
—
0
6
0
9
0.00
0.00
0.0
1.8
—
1.2
—
0
9
8
83
0.96
0.00
1.0
1.1
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint CD2_BENIGN_BONE_SCAPULA_LONG_UPPER and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_BONE_SCAPULA_LONG_UPPER 1.04 [0.75, 1.44] 0.814
Birth year 0.993 [0.98, 1.0] 0.1

During the follow-up period (1.1.1998 — 31.12.2019), 53 out of 841 females with CD2_BENIGN_BONE_SCAPULA_LONG_UPPER died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_BONE_SCAPULA_LONG_UPPER 0.846 [0.65, 1.1] 0.217
Birth year 0.987 [0.98, 1.0] 0.007

During the follow-up period (1.1.1998 — 31.12.2019), 69 out of 986 males with CD2_BENIGN_BONE_SCAPULA_LONG_UPPER died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_BONE_SCAPULA_LONG_UPPER.

N-year risk Females Males
1 0.075% 0.198%
5 0.646% 1.007%
10 1.443% 2.695%
15 2.829% 5.179%
20 5.114% 8.344%

Relationships between endpoints

Index endpoint: CD2_BENIGN_BONE_SCAPULA_LONG_UPPER – Benign neoplasm: Scapula and long bones of upper limb

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data